^
CANCER:

Small Cell Lung Cancer

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
No biomarker
Small Cell Lung Cancer
lurbinectedin
Sensitive
:
A1
Pharmamar Press Release - 5 days - (New A1)
No biomarker
Small Cell Lung Cancer
durvalumab
Sensitive
:
A1
No biomarker
Small Cell Lung Cancer
atezolizumab
Sensitive
:
A1
No biomarker
Small Cell Lung Cancer
topotecan
Sensitive
:
A1
No biomarker
Small Cell Lung Cancer
CAV
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
nivolumab
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
pembrolizumab
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
paclitaxel
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
docetaxel
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
temozolomide
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
etoposide oral
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
vinorelbine tartrate
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
gemcitabine
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
bendamustine
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
irinotecan
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
bevacizumab
Resistant
:
A2
No biomarker
Small Cell Lung Cancer
cisplatin
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
carboplatin
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
carboplatin + etoposide IV
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
cisplatin + etoposide IV
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
carboplatin + gemcitabine
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
cisplatin + topotecan
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
cisplatin + irinotecan
Sensitive
:
A2
No biomarker
Small Cell Lung Cancer
trilaciclib
Sensitive
:
B
PD-L1 expression
Small Cell Lung Cancer
atezolizumab
Sensitive
:
B
No biomarker
Small Cell Lung Cancer
CS 2164
Sensitive
:
B
No biomarker
Small Cell Lung Cancer
nanoliposomal irinotecan
Sensitive
:
B
TMB-H
Small Cell Lung Cancer
nivolumab + ipilimumab
Sensitive
:
B
TMB-H
Small Cell Lung Cancer
nivolumab
Sensitive
:
B
HLA-DQB1*03:01
Small Cell Lung Cancer
durvalumab + CP-675206
Sensitive
:
B
HER-2 positive
Small Cell Lung Cancer
trastuzumab
Sensitive
:
C1
NTRK3 fusion
Small Cell Lung Cancer
larotrectinib
Sensitive
:
C1
NTRK2 fusion
Small Cell Lung Cancer
larotrectinib
Sensitive
:
C1